These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation. Edelson JB; Zak V; Goldberg D; Fleming G; Mackie AS; Patel JK; Files M; Downing T; Richmond M; Acheampong B; Cartoski M; Detterich J; McCrindle B; McHugh K; Hansen JE; Wagner J; Maria MD; Weingarten A; Nowlen T; Yoon JK; Kim GB; Williams R; Whitehill R; Kirkpatrick E; Yin S; Ermis P; Lubert AM; Stylianou M; Freemon D; Hu C; Garuba OD; Frommelt P; Goldstein BH; Paridon S; Garg R; Am J Cardiol; 2024 Jan; 210():183-187. PubMed ID: 37918818 [TBL] [Abstract][Full Text] [Related]
5. Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation. Goldberg DJ; Zak V; Goldstein BH; Chen S; Hamstra MS; Radojewski EA; Maunsell E; Mital S; Menon SC; Schumacher KR; Payne RM; Stylianou M; Kaltman JR; deVries TM; Yeager JL; Paridon SM; Am Heart J; 2017 Jun; 188():42-52. PubMed ID: 28577680 [TBL] [Abstract][Full Text] [Related]
6. The use of Macitentan in Fontan circulation: a case report. Demetriades P; Aziz A; Condliffe R; Bowater SE; Clift PF BMC Cardiovasc Disord; 2017 May; 17(1):131. PubMed ID: 28532389 [TBL] [Abstract][Full Text] [Related]
7. The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis. Goldberg DJ; Hu C; Lubert AM; Rathod RH; Penny DJ; Petit CJ; Schumacher KR; Ginde S; Williams RV; Yoon JK; Kim GB; Nowlen TT; DiMaria MV; Frischhertz BP; Wagner JB; McHugh KE; McCrindle BW; Cartoski MJ; Detterich JA; Yetman AT; John AS; Richmond ME; Yung D; Payne RM; Mackie AS; Davis CK; Shahanavaz S; Hill KD; Almaguer M; Zak V; McBride MG; Goldstein BH; Pearson GD; Paridon SM; Pediatr Cardiol; 2023 Dec; 44(8):1691-1701. PubMed ID: 37382636 [TBL] [Abstract][Full Text] [Related]
8. Udenafil to FUEL exercise performance in individuals with Fontan physiology. Lim GB Nat Rev Cardiol; 2020 Feb; 17(2):72. PubMed ID: 31797909 [No Abstract] [Full Text] [Related]
9. Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation. Agnoletti G; Gala S; Ferroni F; Bordese R; Appendini L; Pace Napoleone C; Bergamasco L J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1468-1475. PubMed ID: 28283234 [TBL] [Abstract][Full Text] [Related]
10. Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements. Latus H; Gerstner B; Kerst G; Moysich A; Gummel K; Apitz C; Bauer J; Schranz D Pediatr Cardiol; 2016 Mar; 37(3):504-11. PubMed ID: 26547436 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Rosenthal M; Bush A; Deanfield J; Redington A Circulation; 1995 Jan; 91(2):372-8. PubMed ID: 7805240 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary blood flow patterns in patients with Fontan circulation. Hager A; Fratz S; Schwaiger M; Lange R; Hess J; Stern H Ann Thorac Surg; 2008 Jan; 85(1):186-91. PubMed ID: 18154807 [TBL] [Abstract][Full Text] [Related]
13. Systemic-to-Pulmonary Collateral Flow Correlates with Clinical Condition Late After the Fontan Procedure. Kodama Y; Ishikawa Y; Kuraoka A; Nakamura M; Oda S; Nakano T; Kado H; Sakamoto I; Ohtani K; Ide T; Tsutsui H; Sagawa K Pediatr Cardiol; 2020 Dec; 41(8):1800-1806. PubMed ID: 32915292 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy. Snarr BS; Paridon SM; Rychik J; Goldberg DJ Cardiol Young; 2015 Dec; 25(8):1489-92. PubMed ID: 26675595 [TBL] [Abstract][Full Text] [Related]
15. Contributions of Respiration and Heartbeat to the Pulmonary Blood Flow in the Fontan Circulation. Honda T; Itatani K; Takanashi M; Kitagawa A; Ando H; Kimura S; Nakahata Y; Oka N; Miyaji K; Ishii M Ann Thorac Surg; 2016 Nov; 102(5):1596-1606. PubMed ID: 27262910 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity? Schuuring MJ; Vis JC; Bouma BJ; van Dijk AP; van Melle JP; Pieper PG; Vliegen HW; Sieswerda GT; Mulder BJ Contemp Clin Trials; 2011 Jul; 32(4):586-91. PubMed ID: 21527360 [TBL] [Abstract][Full Text] [Related]
17. The effect of bosentan in patients with a failing Fontan circulation. Ovaert C; Thijs D; Dewolf D; Ottenkamp J; Dessy H; Moons P; Gewillig M; Mertens L Cardiol Young; 2009 Aug; 19(4):331-9. PubMed ID: 19519964 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary and caval blood flow patterns in patients with intracardiac and extracardiac Fontan: a magnetic resonance study. Klimes K; Abdul-Khaliq H; Ovroutski S; Hui W; Alexi-Meskishvili V; Spors B; Hetzer R; Felix R; Lange PE; Berger F; Gutberlet M Clin Res Cardiol; 2007 Mar; 96(3):160-7. PubMed ID: 17180575 [TBL] [Abstract][Full Text] [Related]
19. Contrast circulation in adult fontan patients using MR Time Resolved Angiography: Application for CT pulmonary angiography. Duerden L; Abdullah H; Lyen S; Manghat N; Hamilton M J Cardiovasc Comput Tomogr; 2020; 14(4):330-334. PubMed ID: 31889659 [TBL] [Abstract][Full Text] [Related]
20. Two problems and a single solution: Covered stent implantation to close an anterograde pulmonary flow and treat hypoplastic left pulmonary artery after Fontan operation. Butera G; Taha F Catheter Cardiovasc Interv; 2016 May; 87(6):E240-2. PubMed ID: 26268838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]